Xiaoyu Zhao

Discovery of Potent Orally Active Protease-Activated Receptor 1 (PAR1) Antagonists Based on Andrographolide.

A. Ji, J. Xing, Jianbo Ji, 2017, Journal of medicinal chemistry.

Antibody evasion of SARS-CoV-2 Omicron BA.1, BA.1.1, BA.2, and BA.3 sub-lineages

Rui Qiao, Yi Li, Lin Li, 2022, Cell Host & Microbe.

Homologous or heterologous booster of inactivated vaccine reduces SARS-CoV-2 Omicron variant escape from neutralizing antibodies

Shibo Jiang, Pengfei Wang, Huanzhang Zhu, 2021, bioRxiv.

Discovery of lysosome-targeted covalent anticancer agents based on isosteviol skeleton.

A. Ji, H. Lou, Lin Li, 2020, European journal of medicinal chemistry.

Design and synthesis of furyl/thineyl pyrroloquinolones based on natural alkaloid perlolyrine, lead to the discovery of potent and selective PDE5 inhibitors.

Jianbo Ji, Lin Li, Bin Sun, 2018, European journal of medicinal chemistry.

Diversity-oriented synthesis of pyrazoles derivatives from flavones and isoflavones leads to the discovery of promising reversal agents of fluconazole resistance in Candida albicans.

Bin Sun, H. Lou, Wenqiang Chang, 2018, Bioorganic & medicinal chemistry letters.

Synthesis and biological evaluation of 6-hydroxyl C-aryl glucoside derivatives as novel sodium glucose co-transporter 2 (SGLT2) inhibitors.

Bin Sun, H. Lou, Hongbo Zheng, 2018, Bioorganic & medicinal chemistry letters.

Antibody Resistance of SARS-CoV-2 Omicron BA.1, BA.1.1, BA.2 and BA.3 Sub-lineages

Rui Qiao, Lin Li, Zixin Hu, 2022, bioRxiv.